The Volta Clinical Evidence Roadmap

One of the most ambitious clinical programs focused on the underserved complex Atrial Fibrillation (AF) patient
The Problem
Underserved population of Complex AFib Patients

70%

of all AFib patients suffer from complex AF1

<50%

of catheter ablation treatments are persistent AF patients2
Our Approach
Industry-Leading Research Scope and quality